Plasma proteome changes in cardiovascular disease patients: Novel isoforms of apolipoprotein A1

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Májek, Pavel ^a   Reicheltová, Zuzana ^a   Suttnar, Jiří ^a   Malý, Martin ^b   Oravec, Milan ^b   Pečánková, Klára ^a   Dyr, Jan E ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; APOLIPOPROTEIN A1; ISOPROTEIN; PLASMA PROTEIN; PROTEOME; VITAMIN D BINDING PROTEIN;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RISK FACTOR; STABLE ANGINA PECTORIS; TANDEM MASS SPECTROMETRY; UNSTABLE ANGINA PECTORIS; WESTERN BLOTTING; AGED; BLOOD; METABOLISM; PRINCIPAL COMPONENT ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AGED; APOLIPOPROTEIN A-I; CARDIOVASCULAR DISEASES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MOLECULAR WEIGHT; PRINCIPAL COMPONENT ANALYSIS; PROTEIN ISOFORMS; PROTEOME;

EID: 79957658070     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-84     Document Type: Article

References (24)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyörälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24:1601-1610. 10.1016/S0195-668X(03)00347-6, 12964575.
2. Dunder K, Lind L, Lagerqvist B, Zethelius B, Vessby B, Lithell H. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction. Am Heart J 2004, 147:502-508. 10.1016/j.ahj.2003.09.010, 14999201.
3. Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC. Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med 2008, 6:46. 10.1186/1479-5876-6-46, 2538501, 18759978.
4. Didangelos A, Simper D, Monaco C, Mayr M. Proteomics of acute coronary syndromes. Curr Atheroscler Rep 2009, 11:188-195. 10.1007/s11883-009-0030-x, 19361350.
5. O'Donnell CJ, Nabel EG. Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era. Circ Cardiovasc Genet 2008, 1:51-57. 10.1161/CIRCGENETICS.108.813337, 3097376, 20031542.
6. Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A, Liu PP. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 2006, 48:1733-1741. 10.1016/j.jacc.2006.06.063, 17084242.
7. Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosová I, Creer MH, Piwnica-Worms D, Kovacs A, Pedersen L, Nolta JA. Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med 2010, 8:24. 10.1186/1479-5876-8-24, 2846892, 20214792.
8. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999, 19:1720-1730. 83965, 10022859.
9. Stanley BA, Gundry RL, Cotter RJ, Van Eyk JE. Heart disease, clinical proteomics and mass spectrometry. Dis Markers 2004, 20:167-178.
10. Berhane BT, Zong C, Liem DA, Huang A, Le S, Edmondson RD, Jones RC, Qiao X, Whitelegge JP, Ping P, Vondriska TM. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005, 5:3520-3530. 10.1002/pmic.200401308, 16052623.
11. Chambers G, Lawrie L, Cash P, Murray GI. Proteomics: a new approach to the study of disease. J Pathol 2000, 192:280-288. 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L, 11054709.
12. Májek P, Reicheltová Z, Stikarová J, Suttnar J, Sobotková A, Dyr JE. Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin. Proteome Sci 2010, 8:56. 2996359, 21073729.
13. Cooper AV, Standeven KF, Ariëns RA. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood 2003, 102:535-540. 10.1182/blood-2002-10-3150, 12663453.
14. Parastatidis I, Thomson L, Burke A, Chernysh I, Nagaswami C, Visser J, Stamer S, Liebler DC, Koliakos G, Heijnen HF, Fitzgerald GA, Weisel JW, Ischiropoulos H. Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem 2008, 283:33846-33853. 10.1074/jbc.M805522200, 2590685, 18818200.
15. Gomme PT, Bertolini J. Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 2004, 22:340-345. 10.1016/j.tibtech.2004.05.001, 15245906.
16. López-Farré AJ, Mateos-Cáceres PJ, Sacristán D, Azcona L, Bernardo E, de Prada TP, Alonso-Orgaz S, Fernández-Arquero M, Fernández-Ortiz A, Macaya C. Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res 2007, 6:2481-2487. 10.1021/pr060600i, 17555340.
17. Itoh H, Ide H, Ishikawa N, Nawa Y. Mast cell protease inhibitor, trypstatin, is a fragment of inter-alpha-trypsin inhibitor light chain. J Biol Chem 1994, 269:3818-3822.
18. Allhorn M, Lundqvist K, Schmidtchen A, Akerström B. Heme-scavenging role of alpha1-microglobulin in chronic ulcers. J Invest Dermatol 2003, 121:640-646. 10.1046/j.1523-1747.2003.12409.x, 12925227.
19. Vyssoulis GP, Tousoulis D, Antoniades C, Dimitrakopoulos S, Zervoudaki A, Stefanadis C. Alpha-1 microglobulin as a new inflammatory marker in newly diagnosed hypertensive patients. Am J Hypertens 2007, 20:1016-1021. 10.1016/j.amjhyper.2007.01.010, 17765145.
20. Mateos-Cáceres PJ, García-Méndez A, López Farré A, Macaya C, Núñez A, Gómez J, Alonso-Orgaz S, Carrasco C, Burgos ME, de Andrés R, Granizo JJ, Farré J, Rico LA. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004, 44:1578-1583. 10.1016/j.jacc.2004.06.073, 15489088.
21. Puchois P, Kandoussi A, Fievet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 1987, 68:35-40. 10.1016/0021-9150(87)90091-8, 3120739.
22. Ishikawa T, Fidge N, Thelle DS, Førde OH, Miller NE. The Tromsø Heart Study: serum apolipoprotein AI concentration in relation to future coronary heart disease. Eur J Clin Invest 1978, 8:179-182. 10.1111/j.1365-2362.1978.tb00832.x, 99314.
23. Reinhart RA, Gani K, Arndt MR, Broste SK. Apolipoproteins A-I and B as predictors of angiographically defined coronary artery disease. Arch Intern Med 1990, 150:1629-1633. 10.1001/archinte.150.8.1629, 2116785.
24. Candiano G, Bruschi M, Petretto A, Santucci L, Del Boccio P, Urbani A, Bertoni E, Gusmano R, Salvadori M, Scolari F, Ghiggeri GM. Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms. Proteomics Clin Appl 2008, 2:956-963. 10.1002/prca.200780157, 21136897.